Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
The decision to discontinue the trial is not due to safety concerns. The discontinuation is based on an analysis of the significant delay in recruitment of patients which is expected to have a negative impact on the outcome of the trial.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Serum albumin as specified in protocol
Malnourished (based on serum albumin value below 40 g/L, assessed centrally)
Stable (for 3 months or more) and adequate haemodialysis treatment three months prior to enrolment as defined by Kt/V of more than 1.2
You may not be if
Active malignant disease
Critical illness requiring treatment in an intensive care unit (ICU)
Uncontrolled treated/untreated hypertension
Patients on chronic (more than 3 months) treatment with steroids in doses of more than 10 mg/day prednisolone (or equivalent)
Patients treated with immunosuppressive agents
Known Growth Hormone Deficiency
Patients suffering from any clinically significant disease history in the opinion of the investigator
Severe illness as defined in the protocol (as judged by the investigator)
Clareo Health | The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis
